1. Lei H, Wang Q, Xiong XM, Hu S, Shao Y, Shao R. Primary symptoms of severe mycoplasma pneumoniae pneumonia with acute abdomen, scrotal swelling and pain, and fever: A case report. Immun Inflamm Dis. 2023;11(10):e955.
2. Otheo E, Rodríguez M, Moraleda C, Domínguez-Rodríguez S, Martín MD, Herreros ML, et al. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain. Pediatr Pulmonol. 2022;57(1):253-63.
3. LUO X Q, LUO J, WANG C J. Clinical features of severe Mycoplasma pneumoniae pneumonia with pulmonary complications in childhood: A retrospective study. Pediatr Pulmonol. 2023;58(10):2815-22.
4. Zhang H, Yang J, Zhao W, Zhou J, He S, Shang Y, et al. Clinical features and risk factors of plastic bronchitis caused by refractory Mycoplasma pneumoniae pneumonia in children: a practical nomogram prediction model. Eur J Pediatr. 2023;182(3):1239-49.
5. Lee E, Choi I. Clinical Usefulness of Serum Lactate Dehydrogenase Levels in Mycoplasma pneumoniae Pneumonia in Children. Indian J Pediatr. 2022;89(10):1003-9.
6. Lee KL, Lee CM, Yang TL, Yen TY, Chang LY, Chen JM, et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010-2019. J Formos Med Assoc. 2021;120(1 Pt 1):281-91.
7. Yin L, Ma Y, Wang W, Zhu Y. The critical function of miR-1323/Il6 axis in children with Mycoplasma pneumoniae pneumonia. J Pediatr (Rio J). 2021;97(5):552-8.
8. Zhang X, Sun R, Jia W, Li P, Song C. A new dynamic nomogram for predicting the risk of severe Mycoplasma pneumoniae pneumonia in children. Sci Rep. 2024,14(1): 8260.
9. Zhou Y, Shan Y, Cui Y, Shi J, Wang F, Miao H, et al. Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study. Crit Care Explor. 2021;3(3):e0366.
10. Xu H, Feng G, Cai S, Liu J, Tang X, Liu H, et al. Predictive Model for Discrimination of Tuberculous Pleural Effusion From Severe Mycoplasma pneumoniae Pneumonic Effusion in Children. Pediatr Infect Dis J. 2019;38(11):1100-3.
11. Chen HR, Zou H, Xue M, Chen ZB, Chen WX. et al. A Case of Childhood COVID-19 Infection with Pleural Effusion Complicated by Possible Secondary Mycoplasma Pneumoniae Infection. Pediatr Infect Dis J. 2020;39(7):e135-e7.
12. Zhu N, Zhou D, Yuan R, Ruzetuoheti Y, Li J, Zhang X, et al. Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children. Clin Respir J. 2023;17(3):187-96.
13. Zhu N, Zhou D, Yuan R, Ruzetuoheti Y, Li J, Zhang X, et al. Identification and comparison of Chlamydia psittaci, Legionella and Mycoplasma pneumonia infection. Clin Respir J. 2023;17(5):384-93.
14. Fan F, Lv J, Yang Q, Jiang F. Clinical characteristics and serum inflammatory markers of community-acquired mycoplasma pneumonia in children. Clin Respir J. 2023;17(7):607-17.
15. Wang F, Cheng Q, Duo H, Wang J, Yang J, Jing S, et al. Childhood Mycoplasma pneumoniae: epidemiology and manifestation in Northeast and Inner Mongolia, China. Microbiology spectrum. 2024;12(5):e0009724.
16. Wang J, Xia C, Sharma A, Gaba GS, Shabaz M. Chest CT Findings and Differential Diagnosis of Mycoplasma pneumoniae Pneumonia and Mycoplasma pneumoniae Combined with Streptococcal Pneumonia in Children. J Healthc Eng. 2021;2021:8085530.
17. Chen Q, Hu T, Wu L, Chen L. Clinical Features and Biomarkers for Early Prediction of Refractory Mycoplasma Pneumoniae Pneumonia in Children. Emerg Med Int. 2024;2024:9328177.
18. Di Teodoro G, Marruchella G, Di Provvido A, D'Angelo AR, Orsini G, Di Giuseppe P, et al. Contagious Bovine Pleuropneumonia: A Comprehensive Overview. Vet Pathol. 2020;57(4):476-89.
19. Poddighe D, Demirkaya E, Sazonov V, Romano M. Mycoplasma pneumoniae Infections and Primary Immune Deficiencies. Int J Clin Pract. 2022;2022:6343818.
20. DING L, ZHAO Y, LI X. Early diagnosis and appropriate respiratory support for Mycoplasma pneumoniae pneumonia associated acute respiratory distress syndrome in young and adult patients: a case series from two centers. BMC Infect Dis. 2020;20(1):367.
21. Zheng B, Zhao J, Cao L. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children. BMC Infect Dis. 2020;20(1):391.
22. Huang X, Li D, Liu F. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2021;21(1):14.
24. Zhu Z, Zhang T, Guo W, Ling Y, Tian J, Xu Y. Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy. BMC Infect Dis. 2021;21(1):126.
25. Yi X, Jia W, Li W, Jia C, Song C. Diagnostic value of cytokines in severe childhood Mycoplasma pneumoniae pneumonia combined with Adenovirus infection [J]. Ital J Pediatr. 2024;50(1):92-9.
26. YANG B, ZHANG W, GU W. Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children. BMC Infect Dis. 2021;21(1):797-9.
27. Liu G, Wang G, Yang Z, Liu G, Ma H, Lv Y, et al. A Lung Ultrasound-Based Nomogram for the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Hospitalized Children. Infect Drug Resist. 2022;15(8):6343-55.
28. YANG L, ZHANG Y, SHEN C, et al. Clinical features and risk factors of plastic bronchitis caused by Mycoplasma pneumoniae pneumonia in children. BMC Pulm Med. 2023;23(1):468.
29. Yang L, Zhang Y, Shen C, Lu Z, Hou T, Niu F, et al. The clinical significance of macrolide resistance in pediatric Mycoplasma pneumoniae infection during COVID-19 pandemic [J]. Frontiers in cellular and infection microbiology, 2023, 13: 1181402.
30. Lu W, Wu X, Xu Y, Wang T, Xiao A, Guo X, et al. Predictive value of bronchoscopy combined with CT score for refractory mycoplasma pneumoniae pneumonia in children [J]. BMC Pulm Med. 2024;24(1):251.
31. Chu C, Lei X, Li Y, Luo Y, Ding Y, Zhou W, et al. High expression of miR-222-3p in children with Mycoplasma pneumoniae pneumonia [J]. Ital J Pediatr. 2019;45(1):163.